Jun 20, 2024, 11:33 by ASAM Weekly Editors

Piloting a Hospital-Based Rapid Methadone Initiation Protocol for Fentanyl

Jun 20, 2024, 11:31 by ASAM Weekly Editors

Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population

Jun 20, 2024, 11:29 by ASAM Weekly Editors

Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco

Jun 13, 2024, 13:44 by Kelly Corredor

ASAM & ACAAM Comment on CMS Rule for GME Fellowships

Jun 13, 2024, 13:29 by Kelly Corredor

Letter to HRSA on reentry program guidance

Jun 13, 2024, 00:31 by Molly McGrath

On June 10th, the Michigan Society of Addiction Medicine (MISAM) sent a comment letter to the Michigan Department of Health and Human Services regarding a proposed policy expanding the services provided by Substance Use Disorder (SUD) Health Homes. Specifically, this proposal would add simulant use disorder and alcohol use disorder as eligible diagnoses for reimbursement.

Jun 7, 2024, 14:15 by Kelly Corredor

Sign-on letter to CMS requests more information and transparency on network adequacy, reimbursement rates and practices, utilization management, cost-sharing, and supplemental benefits.

Jun 7, 2024, 14:07 by Molly McGrath

ASAM signed a letter spearheaded by the Campaign for Tobacco-Free Kids, sent to the leadership of the House Appropriations Committee, urging their approval of the full authorized level of tobacco user fees, and their opposition any efforts to weaken or alter the Food and Drug Administration's authority over tobacco products in the appropriations process.

Jun 6, 2024, 17:46 by Kelly Corredor

New ASAM resource on Medicare coverage of injectable addiction treatment medications.

Jun 3, 2024, 22:29 by Molly McGrath

The recent article “Has Fentanyl Peaked?” in The New York Times had me asking a different question: How much do we care about Americans with addiction, dying at unprecedented numbers from an increasingly lethal drug supply?

May 28, 2024, 16:33 by Molly McGrath

A group of over fifty stakeholders and leaders called on the Biden Administration to rescind a $75 'cap' per patient per budget year on incentives in contingency management for treating stimulant use disorder (StimUD).

May 28, 2024, 15:02 by ASAM Weekly Editors

Rapid Initiation of Injection Naltrexone for Opioid Use Disorder

May 22, 2024, 15:14 by Molly McGrath

On May 17th, Louisiana Society of Addiction Medicine (LASAM) sent a letter of opposition to SB 276 ahead of its consideration by the Louisiana House of Representatives. SB 276 would designate mifepristone as a controlled substance.

May 22, 2024, 08:50 by ASAM Weekly Editors

Burden of Mental Disorders and Suicide Attributable to Childhood Maltreatment

May 17, 2024, 07:29 by Molly McGrath

On May 14th, the Louisiana Society of Addiction Medicine (LASAM) sent a letter supporting SB 190 that would raise Medicaid reimbursement rates for physician services, including substance use disorder (SUD) treatment, to members of the House Committee on Health and Welfare.

May 15, 2024, 09:08 by Molly McGrath

The letter asks Congress to fund the SUD Treatment and Recovery Loan Repayment Program (STAR-LRP) at $50 million, and the Addiction Medicine Fellowship (AMF) Program at $30 million, in Fiscal Year 2025.

May 15, 2024, 08:08 by Molly McGrath

The Colorado Society of Addiction Medicine (COSAM) sent a letter to members of the Pueblo City Council opposing a proposed ordinance banning the operation of syringe service programs (SSPs),

May 14, 2024, 14:52 by ASAM Weekly Editors

Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior

May 10, 2024, 12:37 by Kelly Corredor

Doctors and Pharmacists groups send letter to federal agencies to highlight buprenorphine access issues in pharmacies and to request clear guidance to ensure patients can get their medications.

May 8, 2024, 12:51 by Kelly Corredor

A new proposed rule from CMS will implement 200 new Medicare-funded residencies and fellowships in 2026.